All News

Research presented at ASHP 2024 found that concerns around the safety of COVID-19 vaccines and the credibility of information from public health authorities were the biggest drivers of vaccine hesitancy during the COVID-19 pandemic.

For Migraine and Headache Awareness Month, Drug Topics spoke with Shivang Joshi, MD, MPH, RPh, FAHS to debunk migraine myths and explore resources to promote migraine awareness and education.

A poster presented at AHS 2024 found that older patients tended to have more vitamin deficiencies compared to younger patients.

Cefepime/enmetazobactam was granted a 5-year exclusivity extension under GAIN Act legislation.

Medication nonadherence can account for up to 50% of treatment failures and over $500 billion in annual health care costs.

In 2 abstracts presented at ASCO 2024, researchers addressed the use of GLP-1s for weight loss and to reduce cardiovascular outcomes in women with breast cancer.

A survey of health system specialty pharmacy employees found that hybrid work significantly improved quality of life and workplace productivity.

Telepharmacy can empower pharmacists to practice at the top of their license, fostering a more efficient and accessible health care system that benefits both patients and providers.

A posted presented at ASHP 2024 examined if improved access to methadone could decrease hospital length of stay and readmission rates.

Skin complications are common in patients with diabetes, but pharmacists can recommend several easy measures to help.

Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, discusses what the future looks like for psychedelic treatments.

Sandra C. Canally, RN, founder and CEO of The Compliance Team, discussed the goals, benefits, and opportunities of value-based care in pharmacy.

In a session presented at the 2024 Heart in Diabetes Conference, Neha Pagidipati, MD, MPH, discussed weight change and its effects on cardiovascular complications.

The 2024 National Impact Assessment of CMS Quality Measures Report found that adherence to medications for cholesterol, hypertension and diabetes helped Medicare beneficiaries avoid up to $29.2 billion dollars in health care costs from 2016-21.

Two posters presented at ENDO 2024 assessed semaglutide’s impact on taste sensitivity and tirzepatide’s role in body weight reduction.

Clinical recommendations for the management of type 1 diabetes (T1D) in older adults are urgently needed as the global population ages and as improved diabetes care and management of complications have extended the life expectancy of the patient population.

In an attempt to promote flu vaccination, Kristen Thorson, PharmD, encourages pharmacists to “know the power of their recommendation.”

Nicolette Mathey, PharmD, founder of ATRIUM24 and Dotti CRM, discussed how new technological tools can help pharmacists care for more patients.

The world’s information is at our fingertips, but understanding that information and applying it to patient care still requires a rigorous education.

In case you missed it, this week we had news about e-cigarette task forces, combination COVID-19–flu vaccines, updating education on LGBT pain management, and more.

Emily Bellan, PharmD candidate at Duquesne University, shares insights on pharmacy school applications, on-campus involvement opportunities, and career paths after graduation.

Although a recent study revealed shortcomings associated with ChatGPT and its guidance on medication use, it doesn’t rule out its potential as a valuable health care tool.

Academic, corporate, and clinical institutions must empower pharmacists to deliver informed and compassionate care to LGBTQ individuals that matches the standard received by their heterosexual and cisgender peers.

In abstracts presented at the 2024 American Society of Clinical Oncology’s annual meeting, researchers addressed the association between heart failure and multiple types of cancers.

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

The therapy from AstraZeneca is indicated to improve glycemic control in patients aged 10 years or older.

The Supreme Court ruled on the question of limiting access to to mifepristone, a key abortion drug that anti-abortion groups have been working to limit across the country.

The APhA urged policy makers to consider these recommendations to avoid further exacerbating effects of the attack on US health systems.